Monday, May 17, 2010 2:42:54 PM
Recent HALO News
- Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction • PR Newswire (US) • 11/14/2024 09:15:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2024 02:36:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:05:56 PM
- HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS • PR Newswire (US) • 10/31/2024 08:01:00 PM
- HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE • PR Newswire (US) • 10/24/2024 10:30:00 AM
- Halozyme to Report Third Quarter 2024 Financial and Operating Results • PR Newswire (US) • 10/23/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2024 10:53:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 08:14:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 08:34:07 PM
- ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • InvestorsHub NewsWire • 10/10/2024 12:09:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 09:39:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/09/2024 08:09:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/08/2024 08:08:02 PM
- Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE® • PR Newswire (US) • 10/03/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/26/2024 10:06:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/26/2024 08:05:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/25/2024 08:00:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/24/2024 08:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 10:49:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 08:01:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:03:48 PM
- Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis • PR Newswire (US) • 09/13/2024 05:30:00 PM
- Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for Multiple Types of Cancer • PR Newswire (US) • 09/13/2024 12:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 09:56:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 08:12:07 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM